Clinic
Planned Parenthood Los Angeles - El Monte Center
Planned Parenthood Los Angeles - El Monte Center was paid $3.75M by Medicaid between Jan 2018 and Dec 2024, across 36 billing codes. Its largest line is J3490, Unclassified drugs — 14% of everything it billed.
33Billing provider infoPLANNED PARENTHOOD LOS ANGELES - EL MONTE CENTER
EL MONTE, CA 91732
EL MONTE, CA 91732
33aNPI1700975927assigned 10/12/2006
33bProvider typeCommunity Health Clinic/Center
28Total paid$3.75M
24GClaims91,063
24DCodes billed36
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Community Health Clinic/Center providers in California
Rank by total paid#111 of 288
Median peer was paid$2.15M
This provider vs. median1.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official PAHL, LINDA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 21,992 | $1.01M | |
| 2019 | 12,267 | $568K | |
| 2020 | 9,381 | $326K | |
| 2021 | 14,491 | $498K | |
| 2022 | 10,918 | $418K | |
| 2023 | 11,452 | $487K | |
| 2024incomplete | 10,562 | $449K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J3490 | Unclassified drugs | 14% | 14,894 | 12,461 | $516K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 13% | 8,708 | 7,820 | $506K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 3,622 | 3,382 | $491K |
| S4993 | Contraceptive pills for birth control | 9.3% | 3,527 | 3,517 | $348K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 9.3% | 3,480 | 3,334 | $347K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 7.6% | 881 | 865 | $284K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.7% | 1,005 | 953 | $213K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 5.0% | 957 | 952 | $186K |
| 99201 | 4.5% | 1,375 | 1,250 | $170K | |
| 87806 | 4.2% | 6,309 | 4,797 | $158K | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 4.1% | 184 | 184 | $155K |
| A4267 | Contraceptive supply, condom, male, each | 1.7% | 11,572 | 11,312 | $65K |
24 more codes
| 11981 | 1.1% | 184 | $41K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 2,715 | $34K |
| 81025 | <1% | 11,050 | $34K | |
| 99401 | <1% | 1,148 | $22K | |
| S5000 | Prescription drug, generic | <1% | 2,991 | $21K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 52 | $21K |
| 57454 | <1% | 303 | $18K | |
| 58300 | <1% | 183 | $17K | |
| 99000 | <1% | 4,628 | $16K | |
| J7304 | Contraceptive supply, hormone containing patch, each | <1% | 54 | $15K |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | <1% | 182 | $14K |
| 83986 | <1% | 4,129 | $11K | |
| 99402 | <1% | 324 | $10K | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 2,676 | $10K |
| 11976 | <1% | 132 | $7K | |
| 86703 | <1% | 518 | $5K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 967 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 303 | $3K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 304 | $3K |
| 58301 | <1% | 78 | $2K | |
| 81002 | <1% | 1,265 | $2K | |
| 86592 | <1% | 271 | $661.53 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 80 | $406.76 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 12 | $182.34 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPAHL, LINDA (CFO)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.